96 One study showed that even though the overall pharmacist intervention rate was low (1.59%), just over 50% of these interventions were considered to be higher than clinically “significant”, including 11% of cases being “very significant” or “extremely significant”, producing an annual net cost benefit of $116,493. 97 This highlights that the presence of a pharmacist in a chemotherapy preparation unit can prevent ADEs in a high-risk environment and result in a noteworthy positive effect on hospital budgets.
1
—
—